Endo Pharmaceuticals (Nasdaq: ENDP) announced today the appointment of David B. Nash, M.D., M.B.A., to the company's board of directors. Dr. Nash is the Founding Dean of the Jefferson School of Population Health at Thomas Jefferson University in Philadelphia. Dr. Nash is internationally recognized for his work in outcomes management, medical staff development and quality-of-care improvement. Dr. Nash is also a member of the Board of Directors of Humana, headquartered in Louisville, Ky. His appointment brings the number of Endo board members to nine.
Roger Kimmel, chairman of the board of Endo Pharmaceuticals, stated: "We are pleased to have David join our board and bring his vast pharmaceutical and healthcare knowledge and experience to our company. We welcome his contributions to our future success as Endo continues to diversify its business in branded and generic prescription pharmaceuticals, as well as devices and services, across therapeutic areas with a core focus in pain and urology."
No comments:
Post a Comment